ZA919030B - Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them - Google Patents
Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA919030B ZA919030B ZA919030A ZA919030A ZA919030B ZA 919030 B ZA919030 B ZA 919030B ZA 919030 A ZA919030 A ZA 919030A ZA 919030 A ZA919030 A ZA 919030A ZA 919030 B ZA919030 B ZA 919030B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- preparation
- pharmaceutical compositions
- compositions containing
- benzoyl proline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909014087A FR2669029B1 (fr) | 1990-11-14 | 1990-11-14 | Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA919030B true ZA919030B (en) | 1992-08-26 |
Family
ID=9402135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA919030A ZA919030B (en) | 1990-11-14 | 1991-11-14 | Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
US (1) | US5332735A (de) |
EP (1) | EP0486386B1 (de) |
JP (1) | JPH078856B2 (de) |
AT (1) | ATE140450T1 (de) |
AU (1) | AU642053B2 (de) |
CA (1) | CA2055326A1 (de) |
DE (1) | DE69120899T2 (de) |
DK (1) | DK0486386T3 (de) |
ES (1) | ES2091310T3 (de) |
FR (1) | FR2669029B1 (de) |
GR (1) | GR3021196T3 (de) |
IE (1) | IE913963A1 (de) |
NZ (1) | NZ240575A (de) |
PT (1) | PT99503B (de) |
ZA (1) | ZA919030B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245712B (it) * | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
FR2680508B1 (fr) * | 1991-08-20 | 1995-03-03 | Adir | Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
PT1156043E (pt) * | 1992-07-24 | 2004-03-31 | Univ California | Drogas que aumentam as respostas sinapticas mediadas por receptores de ampa |
CA2227237C (en) | 1995-07-26 | 2005-12-13 | Pfizer Inc. | N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
EP1524265A1 (de) * | 2003-10-15 | 2005-04-20 | Newron Pharmaceuticals S.p.A. | Prolinamide-Derivate als Natrium- und/oder Kalziumkanalblocker oder selektive MAO-B Inhibitoren |
MX2007001337A (es) * | 2004-08-02 | 2008-03-13 | Genmedica Therapeutics Sl | Compuestos para inhibir amina-oxidasas que contienen cobre y usos de los mismos. |
SI1856102T1 (sl) * | 2005-02-28 | 2009-12-31 | Tseti Ioulia | Zdravila za Alzheimerjevo bolezen |
EP1877379B1 (de) | 2005-04-13 | 2013-01-16 | Astex Therapeutics Limited | Hydroxybenzamidderivate und ihre verwendung als hsp90-inhibitoren |
US7754725B2 (en) * | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
EP2073807A1 (de) * | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
GB0620259D0 (en) * | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
US8916552B2 (en) | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
EP2073804B1 (de) | 2006-10-12 | 2017-09-13 | Astex Therapeutics Limited | Hydroxy-substituierte benzoesäureamid-verbindungen zur verwendung in der behandlung von schmerzen |
WO2008044027A2 (en) * | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
US8277807B2 (en) | 2006-10-12 | 2012-10-02 | Astex Therapeutics Limited | Pharmaceutical combinations |
GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3524849A (en) * | 1967-10-27 | 1970-08-18 | Hoffmann La Roche | Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein |
JPS5015793B2 (de) * | 1972-06-07 | 1975-06-07 | ||
US3763183A (en) * | 1972-07-10 | 1973-10-02 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines |
US4123544A (en) * | 1977-03-02 | 1978-10-31 | Merrell Toraude S. A. | Acetylsalicylic acid derivatives |
JPS5419969A (en) * | 1977-07-15 | 1979-02-15 | Yoshitomi Pharmaceut Ind Ltd | Proline derivative and its preparation |
US4427587A (en) * | 1982-11-10 | 1984-01-24 | Bristol-Myers Company | Total synthesis of antitumor antibiotics BBM-2040A and BBM-2040B |
JPS6137764A (ja) * | 1984-07-31 | 1986-02-22 | Suntory Ltd | 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物 |
JPH0623190B2 (ja) * | 1985-04-16 | 1994-03-30 | サントリー株式会社 | インヒビタ−活性を有するn−アシルピロリジン誘導体及びその製法並びに用途 |
US4880827A (en) * | 1986-03-18 | 1989-11-14 | Sumitomo Pharmaceuticals Company, Ltd. | Pyrrolidine derivatives having inhibitory action for proline specific endopepidase |
US4833155A (en) * | 1986-11-25 | 1989-05-23 | Syntex (U.S.A.) Inc. | 3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof |
US4912231A (en) * | 1987-06-15 | 1990-03-27 | E. R. Squibb & Sons, Inc. | Process for preparing (trans)-4-phenyl-L-proline derivatives |
NZ228329A (en) * | 1988-03-18 | 1991-12-23 | Mitsui Toatsu Chemicals | Catechol derivatives and pharmaceutical compositions thereof |
US5053414A (en) * | 1988-04-08 | 1991-10-01 | Ono Pharmaceutical Co., Ltd. | Heterocyclic compounds |
US5142065A (en) * | 1988-08-20 | 1992-08-25 | Bayer Aktiengesellschaft | 3-aryl-pyrrolidine-2,4-diones |
-
1990
- 1990-11-14 FR FR909014087A patent/FR2669029B1/fr not_active Expired - Fee Related
-
1991
- 1991-11-13 CA CA002055326A patent/CA2055326A1/fr not_active Abandoned
- 1991-11-13 NZ NZ240575A patent/NZ240575A/xx unknown
- 1991-11-13 AU AU87776/91A patent/AU642053B2/en not_active Ceased
- 1991-11-13 PT PT99503A patent/PT99503B/pt not_active IP Right Cessation
- 1991-11-14 DK DK91403044.0T patent/DK0486386T3/da active
- 1991-11-14 AT AT91403044T patent/ATE140450T1/de not_active IP Right Cessation
- 1991-11-14 JP JP3299228A patent/JPH078856B2/ja not_active Expired - Lifetime
- 1991-11-14 US US07/792,238 patent/US5332735A/en not_active Expired - Fee Related
- 1991-11-14 EP EP91403044A patent/EP0486386B1/de not_active Expired - Lifetime
- 1991-11-14 IE IE396391A patent/IE913963A1/en unknown
- 1991-11-14 ZA ZA919030A patent/ZA919030B/xx unknown
- 1991-11-14 DE DE69120899T patent/DE69120899T2/de not_active Expired - Fee Related
- 1991-11-14 ES ES91403044T patent/ES2091310T3/es not_active Expired - Lifetime
-
1996
- 1996-09-30 GR GR960402551T patent/GR3021196T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FR2669029B1 (fr) | 1994-09-02 |
NZ240575A (en) | 1993-07-27 |
AU8777691A (en) | 1992-05-21 |
PT99503A (pt) | 1992-09-30 |
DE69120899D1 (de) | 1996-08-22 |
ATE140450T1 (de) | 1996-08-15 |
GR3021196T3 (en) | 1996-12-31 |
FR2669029A1 (fr) | 1992-05-15 |
DE69120899T2 (de) | 1997-02-27 |
AU642053B2 (en) | 1993-10-07 |
PT99503B (pt) | 1999-04-30 |
CA2055326A1 (fr) | 1992-05-15 |
JPH078856B2 (ja) | 1995-02-01 |
IE913963A1 (en) | 1992-05-20 |
JPH04283561A (ja) | 1992-10-08 |
DK0486386T3 (da) | 1996-11-25 |
US5332735A (en) | 1994-07-26 |
EP0486386A3 (en) | 1992-10-14 |
EP0486386B1 (de) | 1996-07-17 |
ES2091310T3 (es) | 1996-11-01 |
EP0486386A2 (de) | 1992-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA926328B (en) | Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them. | |
ZA926276B (en) | 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them. | |
IL76454A (en) | Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them | |
CA2119853A1 (fr) | Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent | |
ZA925783B (en) | 5-Isoquinolinesulfonamides, process for preparing them and pharmaceutical compositions containing them. | |
ZA919030B (en) | Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them | |
AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
HU9802143D0 (en) | New heterocyclic compounds of 5 members in the ring, process for producing them and pharmaceutical compositions containing them | |
ZA944728B (en) | alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
ZA926277B (en) | 1-(alkoxybenzyl)piperazine amide compounds, process for preparing them and pharmaceutical compositions containing them. | |
CA2137889A1 (fr) | Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ZA925782B (en) | N-(isoquinolin-5-ylsulphonyl) azacycloalkanes, process for the preparation thereof and pharmaceutical compositions containing them. | |
DK0578521T3 (da) | Hidtil ukendt peptid-derivater med bradykininantagonistisk virkning, fremgangsmåde til fremstilling af derivaterne og farmaceutiske sammensætninger indeholdende disse | |
GR3017280T3 (en) | Aminoalkylchromones, process for their preparation and compositions containing them. | |
HUT55033A (en) | Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same | |
HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds | |
TW232011B (de) | ||
IL97780A0 (en) | Substituted 3-thia-and 3-oxa-alkylflavones,a process for their preparation,the use thereof,medicaments based on these compounds and intermediates |